A Market Correction Is Long Overdue And The Current Spike In Oil Prices Is Insignificant

The markets have had few news to react to and has been trending higher for a long period. Is a pullback or a correction overdue? Hank Smith, Chief Investment Office at Haverford Investments, believes this is an understatement. In an interview for CNBC, he argues it has been almost three years since the market has registered a significant correction (between 10% and 19%), but is not sure what to make of the 200 point drop in the Dow Jones Industrial Average in the last couple of days.

“Whether it’s going to be a pullback […] or a full-fledged correction, I’m not sure. I’m more certain that whatever it is, it’s going to be relatively short-lived”, said Smith.

According to him, there are a large number of investors who are currently on the sidelines, but will be looking for opportunities to enter the market.

Another interview participant, Maury Harris, UBS chief U.S. economist, argues the current spike in oil prices is not a source of concern and that it will not have a meaningful impact on the consumers.

“We’ve seen gasoline prices go up before and the American consumer knows they go up, they go down; they’re a yo-yo”, he said.

Harris claims the consumers will not change their behavior as the current developments are temporary. Therefore, he concludes that the economic consequences will not be substantial. Harris argues that the developments in the labor markets are of a greater importance. He believes the economy still has room for growth before inflation becomes a problem and is of the opinion that “more money in the hands of workers” thorough higher wages and more jobs will lead to more spending over the summer. Harris argues that this is far more important than a temporary rise in oil prices.

Watch the full video here:

Disclosure: none.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!